Youki Ueda

762 total citations
40 papers, 395 citations indexed

About

Youki Ueda is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Youki Ueda has authored 40 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Hepatology and 11 papers in Immunology. Recurrent topics in Youki Ueda's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Youki Ueda is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (10 papers). Youki Ueda collaborates with scholars based in Japan, United States and United Kingdom. Youki Ueda's co-authors include Hiromichi Dansako, Nobuyuki Kato, Shinya Satoh, Masanori Ikeda, Kyoko Mori, Nobuaki Okumura, Masashi Mizokami, Masaya Sugiyama, Shigeharu Kittaka and Taku Iiyama and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Youki Ueda

36 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Youki Ueda Japan	10	130	112	101	93	58	40	395
Kaori Masuda Japan	11	57 0.4×	212 1.9×	130 1.3×	44 0.5×	24 0.4×	17	617
Michael G. Darcy United States	12	65 0.5×	56 0.5×	135 1.3×	82 0.9×	60 1.0×	13	524
Yi Mao China	13	36 0.3×	137 1.2×	236 2.3×	104 1.1×	40 0.7×	20	634
Sheng Shen China	16	40 0.3×	280 2.5×	103 1.0×	106 1.1×	82 1.4×	54	630
Daniel Konstantinovsky United States	8	122 0.9×	97 0.9×	416 4.1×	33 0.4×	115 2.0×	11	708
A. De Smet Belgium	11	98 0.8×	144 1.3×	141 1.4×	12 0.1×	42 0.7×	27	480
Tim Middleton United States	13	25 0.2×	130 1.2×	187 1.9×	180 1.9×	155 2.7×	20	499
Rina Levy Israel	15	205 1.6×	38 0.3×	317 3.1×	16 0.2×	69 1.2×	22	618

Countries citing papers authored by Youki Ueda

Since Specialization

Citations

This map shows the geographic impact of Youki Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youki Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youki Ueda more than expected).

Fields of papers citing papers by Youki Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youki Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youki Ueda. The network helps show where Youki Ueda may publish in the future.

Co-authorship network of co-authors of Youki Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Youki Ueda. A scholar is included among the top collaborators of Youki Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youki Ueda. Youki Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magari, Masaki, Youki Ueda, Takamasa Ishino, et al.. (2025). Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy. Cancer Research. 85(6). 1082–1096. 2 indexed citations

Ishino, Takamasa, Kiichiro Ninomiya, Kota Tachibana, et al.. (2025). High Antigenicity for T_reg Cells Confers Resistance to PD‐1 Blockade Therapy via High PD‐1 Expression in T_reg Cells. Cancer Science. 116(5). 1214–1226. 1 indexed citations

Nagasaki, Joji, Takamasa Ishino, Youki Ueda, et al.. (2025). Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity. Cancer Immunology Research. 13(9). 1471–1484.

Ueda, Youki, et al.. (2025). Liver quad culture chip as a model for radiation injury research. Scientific Reports. 15(1). 12414–12414. 1 indexed citations

Kanno, Toshio, Youki Ueda, Hikari K. Asou, et al.. (2024). Fatty acid metabolism constrains Th9 cell differentiation and antitumor immunity via the modulation of retinoic acid receptor signaling. Cellular and Molecular Immunology. 21(11). 1266–1281. 9 indexed citations

Ueda, Youki, et al.. (2024). Developing an RNA Signature for Radiation Injury Using a Human Liver-on-a-Chip Model. Radiation Research. 202(3). 489–502. 5 indexed citations

Zhu, Li, Joji Nagasaki, Yoshihiro Otani, et al.. (2023). Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models. Cancer Science. 114(10). 3848–3856. 6 indexed citations

Aryankalayil, Molykutty J., et al.. (2023). Biomarkers for Biodosimetry and Their Role in Predicting Radiation Injury. Cytogenetic and Genome Research. 163(3-4). 103–109. 5 indexed citations

Watanabe, Tomofumi, Takamasa Ishino, Youki Ueda, et al.. (2023). Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity. Cancer Science. 114(5). 1859–1870. 30 indexed citations

10.

Ishino, Takamasa, Shusuke Kawashima, Etsuko Tanji, et al.. (2023). Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens. British Journal of Cancer. 128(6). 1166–1175. 7 indexed citations

11.

Satoh, Shinya, et al.. (2020). Identification of ribavirin-responsive cis-elements for GPAM suppression in the GPAM genome. Biochemical and Biophysical Research Communications. 533(1). 148–154. 1 indexed citations

12.

Kato, Nobuyuki, Youki Ueda, Shinya Satoh, et al.. (2019). Study of multiple genetic variations caused by persistent hepatitis C virus replication in long-term cell culture. Archives of Virology. 165(2). 331–343. 3 indexed citations

13.

Imai, Hirotaka, Hiromichi Dansako, Youki Ueda, Shinya Satoh, & Nobuyuki Kato. (2018). Daunorubicin, a topoisomerase II poison, suppresses viral production of hepatitis B virus by inducing cGAS-dependent innate immune response. Biochemical and Biophysical Research Communications. 504(4). 672–678. 20 indexed citations

14.

Ueda, Youki, Hiromichi Dansako, Hye‐Sook Kim, et al.. (2018). Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251. Biochemistry and Biophysics Reports. 15. 1–6. 2 indexed citations

15.

Satoh, Shinya, Kyoko Mori, Youki Ueda, et al.. (2015). Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype. PLoS ONE. 10(2). e0118313–e0118313. 7 indexed citations

16.

Dansako, Hiromichi, Youki Ueda, Nobuaki Okumura, et al.. (2015). The cyclic GMP‐AMP synthetase–STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly. FEBS Journal. 283(1). 144–156. 77 indexed citations

17.

Haraguchi, Kazuhiro, Yasuyuki Kitagawa, Hiromichi Tanaka, et al.. (2014). Synthesis of 3′,4′-difluoro-3′-deoxyribonucleosides and its evaluation of the biological activities: Discovery of a novel type of anti-HCV agent 3′,4′-difluorocordycepin. Bioorganic & Medicinal Chemistry. 22(21). 6174–6182. 5 indexed citations

18.

Ueda, Youki, Kyoko Mori, Shinya Satoh, et al.. (2014). Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris. Biochemical and Biophysical Research Communications. 447(2). 341–345. 30 indexed citations

19.

Ueda, Youki, Kyoko Mori, Hiromichi Dansako, et al.. (2013). New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication. PLoS ONE. 8(8). e72519–e72519. 7 indexed citations

20.

Ueda, Youki, Masao Ōhashi, Kenji Matsuno, et al.. (2013). Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication. Bioorganic & Medicinal Chemistry Letters. 23(17). 4774–4778. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaori Masuda Breakdown of academic impact, for papers by Michael G. Darcy Breakdown of academic impact, for papers by Yi Mao Breakdown of academic impact, for papers by Sheng Shen Breakdown of academic impact, for papers by Daniel Konstantinovsky Breakdown of academic impact, for papers by A. De Smet Breakdown of academic impact, for papers by Tim Middleton Breakdown of academic impact, for papers by Rina Levy